Cargando…

Drug-Induced Kounis Syndrome: Latest Novelties

Kounis syndrome (KS) is defined by an acute coronary syndrome associated with hypersensitivity reactions, an under-diagnosed life-threatening medical emergency. Although multiple causes have been described, drugs constitute the most frequent cause. The purpose of this review is to update knowledge a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ollo-Morales, Paula, Gutierrez-Niso, Marta, De-la-Viuda-Camino, Elena, Ruiz-de-Galarreta-Beristain, Marina, Osaba-Ruiz-de-Alegria, Ixone, Martel-Martin, Carlota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227395/
https://www.ncbi.nlm.nih.gov/pubmed/37361641
http://dx.doi.org/10.1007/s40521-023-00342-9
_version_ 1785050762008592384
author Ollo-Morales, Paula
Gutierrez-Niso, Marta
De-la-Viuda-Camino, Elena
Ruiz-de-Galarreta-Beristain, Marina
Osaba-Ruiz-de-Alegria, Ixone
Martel-Martin, Carlota
author_facet Ollo-Morales, Paula
Gutierrez-Niso, Marta
De-la-Viuda-Camino, Elena
Ruiz-de-Galarreta-Beristain, Marina
Osaba-Ruiz-de-Alegria, Ixone
Martel-Martin, Carlota
author_sort Ollo-Morales, Paula
collection PubMed
description Kounis syndrome (KS) is defined by an acute coronary syndrome associated with hypersensitivity reactions, an under-diagnosed life-threatening medical emergency. Although multiple causes have been described, drugs constitute the most frequent cause. The purpose of this review is to update knowledge about drug-induced KS, to give guidelines on the correct diagnosis and treatment. This article reviews the literature on drug-induced KS from the last 5 years. Antibiotics and NSAIDs are the most frequently implicated drugs. In addition, data on pathophysiology, clinical presentation, diagnosis, and management are reviewed in detail. Highlight that there is a great deal of variability in the diagnosis and especially in the treatment of KS. This review provides a valuable selection of practical resources for all stakeholders to support effective care for KS, from a cardiologic and allergologic point of view. Future research should focus on developing validated, evidence-based, and patient-centered tools to improve the management of KS.
format Online
Article
Text
id pubmed-10227395
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-102273952023-06-01 Drug-Induced Kounis Syndrome: Latest Novelties Ollo-Morales, Paula Gutierrez-Niso, Marta De-la-Viuda-Camino, Elena Ruiz-de-Galarreta-Beristain, Marina Osaba-Ruiz-de-Alegria, Ixone Martel-Martin, Carlota Curr Treat Options Allergy Article Kounis syndrome (KS) is defined by an acute coronary syndrome associated with hypersensitivity reactions, an under-diagnosed life-threatening medical emergency. Although multiple causes have been described, drugs constitute the most frequent cause. The purpose of this review is to update knowledge about drug-induced KS, to give guidelines on the correct diagnosis and treatment. This article reviews the literature on drug-induced KS from the last 5 years. Antibiotics and NSAIDs are the most frequently implicated drugs. In addition, data on pathophysiology, clinical presentation, diagnosis, and management are reviewed in detail. Highlight that there is a great deal of variability in the diagnosis and especially in the treatment of KS. This review provides a valuable selection of practical resources for all stakeholders to support effective care for KS, from a cardiologic and allergologic point of view. Future research should focus on developing validated, evidence-based, and patient-centered tools to improve the management of KS. Springer International Publishing 2023-05-30 /pmc/articles/PMC10227395/ /pubmed/37361641 http://dx.doi.org/10.1007/s40521-023-00342-9 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Ollo-Morales, Paula
Gutierrez-Niso, Marta
De-la-Viuda-Camino, Elena
Ruiz-de-Galarreta-Beristain, Marina
Osaba-Ruiz-de-Alegria, Ixone
Martel-Martin, Carlota
Drug-Induced Kounis Syndrome: Latest Novelties
title Drug-Induced Kounis Syndrome: Latest Novelties
title_full Drug-Induced Kounis Syndrome: Latest Novelties
title_fullStr Drug-Induced Kounis Syndrome: Latest Novelties
title_full_unstemmed Drug-Induced Kounis Syndrome: Latest Novelties
title_short Drug-Induced Kounis Syndrome: Latest Novelties
title_sort drug-induced kounis syndrome: latest novelties
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227395/
https://www.ncbi.nlm.nih.gov/pubmed/37361641
http://dx.doi.org/10.1007/s40521-023-00342-9
work_keys_str_mv AT ollomoralespaula druginducedkounissyndromelatestnovelties
AT gutierreznisomarta druginducedkounissyndromelatestnovelties
AT delaviudacaminoelena druginducedkounissyndromelatestnovelties
AT ruizdegalarretaberistainmarina druginducedkounissyndromelatestnovelties
AT osabaruizdealegriaixone druginducedkounissyndromelatestnovelties
AT martelmartincarlota druginducedkounissyndromelatestnovelties